Clinical trials recruiting in Caledonia, Michigan

Phase breakdown

Conditions recruiting in Caledonia, Michigan

Recruiting trials in Caledonia, Michigan

• A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
  NCT06857942 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female)
• Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
  NCT07645820 · Phase: Not specified · Ages: 12 Years to 89 Years · Sex: All (male and female)
• Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
  NCT06988605 · Phase: Not specified · Ages: 12 Years and older · Sex: All (male and female)
• This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
  NCT07290803 · Phase: Not specified · Ages: 12 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Caledonia, Michigan?

4 recruiting trials have at least one study site in Caledonia, Michigan.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.